The candidate must have Post graduate degrees in biomedical sciences, biotechnology relevance to drug delivery, biological therapeutics, pharmaceutical sciences, Biotechnology.

Post Graduate Degree in Science M.Pharm, Life Science, Biotech, Zoology, Botany, etc. with PG Diploma in Clinical Research is Mandatory.

The candidate must have First class post graduate degrees or second-class post graduate with PhD degree in relevance to nano technology, nano-delivery, biological therapeutics, pharmaceutical sciences, Biotechnology.

master degree in Physical Sciences, Chemical Sciences, Biological Sciences, Mathematical Sciences, or 4 yr-engineering degree in any discipline.

Applications for a postdoctoral position to study mitochondrial regulation of NK cell activation and tumor immunity. This is for a collaborative project between TIFR Hyderabad and Tata Memorial Cancer Centre.

Cadila Pharmaceuticals is an Indian multinational pharmaceutical company based in Ahmedabad.

Designing formulation and process strategies, planning and execution of activities. Development of robust and scalable product within targeted time limits which includes comprehensive reviews of literature, pre-formulation trials, laboratory experiments and ELN writing with detailed observations.

Prepare technology transfer documents and support successful transfer to plant or pilot scale manufacturing site.

Ipca Laboratories Limited Invites experienced, dynamic, and self motivated candidates. Protocol Preparation and Compilation Report of Process Validation, ANDA, Hold Time Study

Indoco Remedies Ltd., is a fully integrated, research-oriented pharma company engaged in the manufacturing and marketing of Formulations and Active Pharmaceutical Ingredients

The study, published online in The Journal of Nutrition, found that consumption of 1-2 cups of caffeinated coffee per day was linked to a lower risk of death from all causes and death from cardiovascular disease.

Regeneron Pharmaceuticals, Inc. and Sanofi announced that the U.S. Food and Drug Administration FDA has approved Dupixent dupilumab for the treatment of adult patients with bullous pemphigoid.

Orion’s collaboration partner Bayer announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended darolutamide, an oral androgen receptor inhibitor , plus androgen deprivation therapy for marketing authorisation in the European Union for the treatment of patients with metastatic hormone-sensitive prostate cancer

A team of physicians from Bochum are the first to successfully use CAR T-cell therapy to treat two patients with a rare autoimmune disease of the peripheral nervous system. This treatment modifies endogenous immune cells such that they can specifically target and eliminate B lymphocytes, which are here the origin of autoimmunity.

Assessment of vacancies of para-medical categories done by Zonal Railways/PUs in the Indent Management module of HRMS has been examined in Railway Board.

PG in Science M.Pharm, Life Science, M.Sc. Biotech, Zoology, Botany, etc. Or Graduation in Science (B.Pharm, Life Science, B.Sc. Biotech, Zoology, Botany, etc with 3 years’ Experience in relevant field. 

Doctoral Degree in Science, Pharma with specialization in Phytochemistry, Natural Products, Organic Chemistry, Analytical Chemistry, Microbiology, Biotechnology.

First class in M.Pharm. or M.S. in Pharmaceutics, Drug delivery, Pharmaceutical Technology, Nanomedicines, or equivalent from a recognized Institute, University.

Post-Graduation in life science. Graduate degree in science with PG Diploma in Clinical Research. Experience of one year in relevant filed is desirable.